A pharmacogenetic analysis of the Canadian Cancer Trials Group MY.10 clinical trial of maintenance therapy for multiple myeloma

Ming Han, Alli Murugesan, Nizar J. Bahlis, Kevin Song, Darrell White, Christine Chen, Matthew D. Seftel, Kang Howsen-Jan, Donna Reece, Keith Stewart, Yagang Xie, Annette E. Hay, Lois Shepherd, Marina Djurfeldt, Liting Zhu, Ralph M. Meyer, Bingshu E. Chen, Tony Reiman

Research output: Contribution to journalLetter

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)732-735
Number of pages4
JournalBlood
Volume128
Issue number5
DOIs
StatePublished - Aug 4 2016

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

Han, M., Murugesan, A., Bahlis, N. J., Song, K., White, D., Chen, C., Seftel, M. D., Howsen-Jan, K., Reece, D., Stewart, K., Xie, Y., Hay, A. E., Shepherd, L., Djurfeldt, M., Zhu, L., Meyer, R. M., Chen, B. E., & Reiman, T. (2016). A pharmacogenetic analysis of the Canadian Cancer Trials Group MY.10 clinical trial of maintenance therapy for multiple myeloma. Blood, 128(5), 732-735. https://doi.org/10.1182/blood-2016-06-716902